- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06741319
Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
The Institute of HIV Research and Innovation (IHRI)
This protocol describes a 20-year prospective cohort study, gathering behavioral and psychosocial information on clients who access services of the Institute of HIV Research and Innovation (IHRI) and the Thai Red Cross AIDS Research Centre through the Thai Red Cross Anonymous Clinic, the Thai Red Cross Mobile Clinics, Affiliated Health Clinics, The gender and immunity clinic and Pribta Tangerine Polyclinic. Services provided through these sites include VCT, STD screening and treatment, anal and cervical Pap smears, general health checkups, sexual health education, and sexual health communication, gender-affirmative hormone therapy (GAHT) and risk-reduction via web boards and chat rooms.
Behavioral and psychosocial information will be collected using validated questionnaires and from data collection forms routinely used when providing services in different service sites of IHRI and the TRC-ARC. The information will be collected anonymously at baseline and at follow-up visits, according to type of services each client receives. Clients at the Thai Red Cross Anonymous Clinic, Thai Red Cross Mobile Health Clinics, Affiliated Health Clinics and Pribta Tangerine Polyclinic will be given an identification number.
Qualitative methods, including focus group discussions (FGD) and in-depth interviews (IDI) will be conducted with clients and healthcare providers to examine the facilitators, barriers, feasibility and acceptability of service implementation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
STUDY OBJECTIVES
- To describe behavioral and psychosocial characteristics of clients who access services.
- To understand the effectiveness of the HIV prevention package offered to clients who access services in terms of cost and infections averted
- To study changes in behavioral and psychosocial characteristics among clients over time
- To study differences in behavioral and psychosocial characteristics among clients by gender identity, sexual orientation, HIV status, and service sites
- To assess behavioral and psychosocial factors that influence the willingness to participate in study trials
- To assess the facilitators, barriers, feasibility and acceptability of and satisfaction with service implementation among clients and healthcare providers under IHRI and TRCARC
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rena Janamnuaysook, MBA
- Phone Number: 6698 516 4562
- Email: rena.j@ihri.org
Study Contact Backup
- Name: Nittaya Phanuphak, MD.,PhD
- Phone Number: 6681 825 3544
- Email: nittaya.p@ihri.org
Study Locations
-
-
Bangkok
-
Pathum Wan, Bangkok, Thailand, 10330
- Recruiting
- Tangerine Clinic, Institute of HIV Research and Innovation
-
Contact:
- Nittaya Phanuphak, MD.,Ph.D.
- Phone Number: +66 2 1605371
- Email: nittaya.p@ihri.org
-
Contact:
- Rena Janamnuaysook, MBA
- Phone Number: +66 2 1605371
- Email: rena.j@ihri.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18 years or 16 and 17 years of age with parental or guardian consent In non- or pre-SRS cases
Recommendation1 by counsellor based on:
A) Presence of GD history B) Understanding of risks and benefits of GAHT D) Practice and readiness for gender transition E) Availability of social support F) Ability to take hormones as instructed
- Verbal informed consent or signed informed consent on file
- No exclusionary medical conditions
- Approved by physician
In SRS- and post-SRS cases2
- Verbal informed consent or signed informed consent on file
- No exclusionary medical conditions
- Approved by physician
Exclusion Criteria:
None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Outcome Measure
Time Frame: 20 years
|
|
20 years
|
Collaborators and Investigators
Investigators
- Study Chair: Siriporn Nonenoy, BNH,MPH, Institute of HIV Research and Innovation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IHRI009
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on Demographic characteristics
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPneumonia | Corona Virus Infection | Acute Respiratory FailureTurkey
-
Hospices Civils de LyonCompletedAdult Patients Developing Optic or Peripheral Neuropathy | While Receiving Tedizolid Therapy Between July 2019 and December 2024France
-
İslam ElagözCompletedNursing Caries | Safety IssuesTurkey
-
RenJi HospitalNot yet recruitingRecurrent MiscarriageChina
-
Hospices Civils de LyonRecruitingEfficacy and Safety of Dalbavancin | In Subjects Who Received SAT with DAL | For Acute or Chronic Infections Between July 2019 and December 2024France
-
Hacettepe UniversityCompletedSingle-ventricle | Exercise Capacity | Hemodynamic Instability | Arterial Stiffness | Muscle Oxygenation | Fontan ProcedureTurkey
-
Hospices Civils de LyonCompletedExcessive Daytime SleepinessFrance
-
Ege UniversityCompletedHeart FailureTurkey
-
University of AberdeenNHS GrampianRecruitingAnorexia Nervosa | AutismUnited Kingdom
-
University Hospital, GhentUniversity GhentCompleted